All In Biotech

Drug Trial Radar · NCT06378138

ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)

A Phase II/III Study of ICP-248 in Combination With Orelabrutinib in Patients With Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Last checked: Nov 19, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

226

Planned (sponsor's estimate)

Start

May 15, 2024

Primary completion

Nov 25, 2030

Study completion Jul 25, 2031

Sponsor

Sponsor type
Industry
First posted
Apr 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the safety, tolerability and pharmacokinetics of ICP-248 in Combination with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Conditions

  • Hematologic Malignancies

Interventions

  • ICP-248Drug

    Eligible patients will receive ICP-248 orally as per the protocol,once daily for every 28 days as one treatment cycle

  • OrelabrutinibDrug

    Eligible patients will receive Orelabrutinib orally as per the protocol,once daily for every 28 days as one treatment cycle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse events (AEs) and serious adverse events (SAEs) evaluation according to CTCAE V5.0 or iwCLL 2018 criteriaTime frame: Up to 6 years
  2. Changes from baseline in pulse.Time frame: Up to 6 years
  3. Changes from baseline in blood pressure.Time frame: Up to 6 years
  4. Changes from baseline in ECG QRS interval.Time frame: Up to 6 years
  5. Changes from baseline in ECG QT interval.Time frame: Up to 6 years

Locations

53 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China · Recruiting

  • Anhui Provincial Hospital (The First Affiliated Hospital of University of Science and Technology of China)

    Hefei, Anhui, China · Recruiting

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Xinqiao Hospital, the Second Affiliated Hospital of Army Military Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China · Recruiting

  • The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China · Recruiting

  • Gansu Provincial People's Hospital

    Lanzhou, Gansu, China · Recruiting

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China · Recruiting

  • Guangdong General Hospital

    Guangzhou, Guangdong, China · Not yet recruiting

  • Nanfang Hospital of Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Not yet recruiting

  • The Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, China · Not yet recruiting

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • The Affiliated Hospital of North China University of Science and Technology

    Tangshan, Hebei, China · Recruiting

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Recruiting

  • Nanyang City Center Hospital

    Nanyang, Henan, China · Recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China · Recruiting

  • Henan Cancer Hospital

    Zhenzhou, Henan, China · Recruiting

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • Union Hospital Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • Yichang Central People's Hospital

    Yichang, Hubei, China · Recruiting

  • The Second Xiangya Hospital, Central South University

    Changsha, Hunan, China · Recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Recruiting

  • Changzhou First People's Hospital

    Changzhou, Jiangsu, China · Not yet recruiting

  • Huai'an First People's Hospital

    Huai'an, Jiangsu, China · Recruiting

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Recruiting

  • Bethune First Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • The Second Hospital of Dalian Medical University

    Dalian, Liaoning, China · Recruiting

  • Shengjing Hospital affiliated to China Medical University

    Shenyang, Liaoning, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Recruiting

  • Shandong Provincial Hospital

    Jinan, Shandong, China · Recruiting

  • Shandong Cancer Hospital

    Jinan, Shandong, China · Recruiting

  • Jining First People's Hospital

    Jining, Shandong, China · Recruiting

  • Linyi City Cancer Hospital

    Linyi, Shandong, China · Recruiting

  • Huashan Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanghai Huashan Hospital

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • The Second Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China · Not yet recruiting

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.